Immunological aspects in chronic lymphocytic leukemia (CLL) development
about
Autoimmune cytopenias in chronic lymphocytic leukemia.Clinical and Laboratory Features of CD5-Negative Chronic Lymphocytic Leukemia.Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.Applied Protein and Molecular Techniques for Characterization of B Cell Neoplasms in Horses.Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia.HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathwayAutophagy contributes to apoptosis in A20 and EL4 lymphoma cells treated with fluvastatinHumoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia.TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?Subclones in B-lymphoma cell lines: isogenic models for the study of gene regulation.Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy.Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency
P2860
Q33407866-4AA83AD4-4DC0-4A24-A73B-85FDEFEB8C3BQ33441622-57595CC1-9C9A-45A2-B7F3-8BC1F994E64DQ34704085-01263791-8861-4F77-BB87-9CA50A9A1B21Q36211658-DC7FA437-E090-4C13-B66E-90446B1C6D3AQ36870866-CC4D7688-C355-43CC-9258-F60865F28191Q37073682-C865060E-7FDC-47C1-8252-412F504214F8Q37320402-E660F9D6-1A2C-4D74-AC01-BFAC6C6976E4Q37709461-37FFF42B-8B1B-4383-97A2-1F46ACBD924CQ38177771-52C38272-9EE0-4CF6-85A9-213A1AA14AE4Q38197232-0415BC25-8610-4862-A99D-EF65EAFA0E27Q38749775-43E09F26-6B49-4DF3-8D1F-96D27AE90099Q38812270-7B3A552A-19B2-43A6-B051-A6E929A60D00Q39225258-3D924451-FE0F-45AF-8B3F-90F0E498F0A7Q52579132-D3F4AD9C-C7BE-410A-9BBE-FF01DA75ABCAQ57110641-5B417FD7-6D05-4CF4-BBD3-4007BEC23CB9
P2860
Immunological aspects in chronic lymphocytic leukemia (CLL) development
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@ast
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@en
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@nl
type
label
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@ast
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@en
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@nl
prefLabel
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@ast
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@en
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@nl
P2093
P2860
P921
P1433
P1476
Immunological aspects in chronic lymphocytic leukemia (CLL) development
@en
P2093
Luis Llorente
Ricardo García-Muñoz
Verónica Roldan Galiacho
P2860
P304
P356
10.1007/S00277-012-1460-Z
P407
P577
2012-07-01T00:00:00Z